Alan Blake is a co-founder and CEO of Nuclein, LLC. Nuclein is working to commercialize a disposable, hand-held COVID-19 PCR testing device. Nuclein’s platform uses standard, real-time PCR, requires no technical expertise and delivers battery-powered, sample-to-answer results in under one hour, without the need to mail in a sample.
 
Alan also co-founded and was CEO of Yorktown Technologies. Yorktown was best known for GloFish®, brilliantly colored fluorescent fish, which are the world’s most visible example of consumer biotechnology and the only widely-marketed biotech animal. GloFish was sold to Spectrum Brands (NYSE: SPB) in 2017. At that point, GloFish were available in over 7,000 retail locations, with roughly 100 GloFish-branded companion products, and underpinned approximately 15% of all sales in the ornamental fish industry.
 
Alan currently serves on the board of Falcon Structures, and he is an Advisory Partner for Trinity Private Equity Group. He has formerly served as the Austin chapter president of the Entrepreneur’s Organization, and as a board member of the Boys & Girls Club of the Austin Area, PrideBites, LLC, and Well Aware, as well as a mentor for Incubation Station (now SKU). Prior to co-founding Yorktown Technologies, Alan founded ClassMap, a venture-funded online learning company that ultimately served professors at 75 universities. Alan is also a winner of the prestigious Austin Under 40 award and holds 21 U.S. patents.
 
Alan graduated from the University of Texas at Austin, where he received a BBA with Highest Honors.